The Food and Drug Administration approved Wednesday the first-ever vaccine to combat severe respiratory syncytial virus, or RSV. Arexvy, the new vaccine developed by GlaxoSmithKline, was approved fo… [+3242 chars]Read More
FDA approves firstever RSV vaccine shots to be available for older adults Yahoo Voices
